Abstract 14604: Impact of Glycated Hemoglobin in Diabetic Patients With Coronary Artery Disease Undergoing Surgery, Angioplasty or Clinical Treatment in a Very Long-Term Follow-Up

IntroductionDiabetes mellitus is considered a significant risk factor in coronary artery disease (CAD). However, prognostic impact of glycemic control in this setting is still controversial.HypothesisTo evaluated the association between glycated hemoglobin levels (HbA1C) and cardiovascular outcomes...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2018-11, Vol.138 (Suppl_1 Suppl 1), p.A14604-A14604
Main Authors: Batista, Daniel V, Hueb, Whady, Linhares Filho, Jaime P, Ribas, Fernando F, Silva, Rafael R, Lima, Eduardo G, Dallazen, Anderson R, Garcia, Rosa M, Rezende, Paulo C, Martins, Eduardo B, Garzillo, Cibele L, Azevedo, Diogo F, Silva, Expedito E, Ramires, Jose A, Kalil Filho, Roberto
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionDiabetes mellitus is considered a significant risk factor in coronary artery disease (CAD). However, prognostic impact of glycemic control in this setting is still controversial.HypothesisTo evaluated the association between glycated hemoglobin levels (HbA1C) and cardiovascular outcomes in diabetic patients undergoing different therapeutic strategies for CAD in a very long-term follow-up.MethodsPatients with diabetes and multivessel CAD who underwent coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI) or optimized medical treatment (OMT) in MASS registry were included. Data were analyzed according to value of baseline glycated hemoglobin in two stratalower (
ISSN:0009-7322
1524-4539